Page last updated: 2024-09-05

4-methyl-3-(phenylsulfonyl)furoxan and oxadiazoles

4-methyl-3-(phenylsulfonyl)furoxan has been researched along with oxadiazoles in 4 studies

Compound Research Comparison

Studies
(4-methyl-3-(phenylsulfonyl)furoxan)
Trials
(4-methyl-3-(phenylsulfonyl)furoxan)
Recent Studies (post-2010)
(4-methyl-3-(phenylsulfonyl)furoxan)
Studies
(oxadiazoles)
Trials
(oxadiazoles)
Recent Studies (post-2010) (oxadiazoles)
5006,0572572,359

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bosia, A; Calvino, R; Fruttero, R; Gasco, A; Ghigo, D; Pescarmona, GP1
Alessio, P; Bosia, A; Calvino, R; Fruttero, R; Gasco, A; Ghigo, D; Heller, R; Pescarmona, G1
Alessio, P; Bussolino, F; Calvino, R; Fruttero, R; Gasco, A; Ghigo, D; Heller, R; Pescarmona, G; Till, U; Todde, R1
Bosia, A; Bussolino, F; Calvino, R; Gasco, A; Ghigo, D; Heller, R; Pescarmona, GP; Till, U1

Other Studies

4 other study(ies) available for 4-methyl-3-(phenylsulfonyl)furoxan and oxadiazoles

ArticleYear
4-Methyl-3-(arylsulfonyl)furoxans: a new class of potent inhibitors of platelet aggregation.
    Journal of medicinal chemistry, 1992, Aug-21, Volume: 35, Issue:17

    Topics: Arachidonic Acid; Blood Platelets; Calcium; Cyclic GMP; Humans; Malondialdehyde; Molecular Structure; Oxadiazoles; Platelet Aggregation Inhibitors; Structure-Activity Relationship

1992
Characterization of a new compound, S35b, as a guanylate cyclase activator in human platelets.
    Biochemical pharmacology, 1992, Mar-17, Volume: 43, Issue:6

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Arachidonic Acid; Blood Platelets; Calcium; Cyclic GMP; Enzyme Activation; Furans; Glutathione; Guanylate Cyclase; Humans; Oxadiazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin Endoperoxides, Synthetic

1992
S35b, a new phenylsulfonylfuroxan compound, inhibits thrombin-induced synthesis of platelet-activating factor and prostacyclin in human endothelial cells.
    Agents and actions, 1993, Volume: 40, Issue:3-4

    Topics: 1-Methyl-3-isobutylxanthine; Acetyltransferases; Cells, Cultured; Colforsin; Cyclic AMP; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Humans; Iloprost; Oxadiazoles; Platelet Activating Factor; Platelet Aggregation Inhibitors; Thrombin; Umbilical Veins

1993
Activation of endothelial guanylate cyclase inhibits cellular reactivity.
    Agents and actions. Supplements, 1995, Volume: 45

    Topics: Arachidonic Acid; Cell Adhesion; Cyclic GMP; Endothelium, Vascular; Enzyme Activation; Epoprostenol; Guanylate Cyclase; Humans; Molsidomine; Nitric Oxide; Nitroprusside; Oxadiazoles; Platelet Activating Factor; Thrombin; Umbilical Veins

1995